文献速递产科母胎医学

远程与居家胎心监护对比传统面对面监护的随机试验系统评价与荟萃分析

Remote and home-based fetal heart rate monitoring for fetal surveillance compared with conventional in-person monitoring: a systematic review and meta-analysis of randomized controlled trials.
PubMed 文献 · Am J Obstet Gynecol MFM · 2026-07-22

该系统评价纳入8项随机对照试验、共1813例妊娠,比较远程或居家胎心监护与常规面对面监护。汇总结果显示,两组5分钟Apgar评分<7(RR 1.01,95%CI 0.73-1.39)与剖宫产(RR 1.09,95%CI 0.94-1.26)均无显著差异,证据确定性为中等。

要点

  • 远程与居家胎心监护未增加5分钟Apgar<7或剖宫产风险
  • 产前与产时监护、不同发表年代的效应均一致
  • 部分试验存在高偏倚风险,Apgar以外的新生儿结局报告不一致

核心结论

  • 随机证据显示,远程与居家胎心监护相比传统面对面监护,5分钟Apgar评分<7与剖宫产无差异。
  • 效应在监护时机(产前与产时)和技术年代间保持一致。
  • 部分试验高偏倚风险,Apgar之外的新生儿结局报告不一致。

研究设计与样本

  • 系统评价与随机对照试验荟萃分析。
  • 纳入8项随机对照试验,共1813例妊娠。
  • 1项试验低偏倚风险,3项有一些担忧,4项高偏倚风险。

主要发现

  • 6项试验(n=1648)报告5分钟Apgar<7,汇总RR 1.01(95%CI 0.73-1.39;I²=0%;τ²=0.00),中等确定性证据。
  • 全部8项试验(n=1813)报告剖宫产,汇总RR 1.09(95%CI 0.94-1.26;I²=0%),中等确定性证据。
  • 亚组分析:监护时机(产前与产时)Qb=1.26,P=.26;发表年代(≥2015与<2015)Qb=1.52,P=.22,均无差异证据。

临床怎么用

  • 远程胎心监护短期围产安全性与面对面监护相当,可考虑作为获取便利的替代方式。
  • 采纳时需综合评估可及性、患者满意度、住院利用、临床医生工作量、数据可靠性与成本。
  • 还需考虑及时临床响应所需的基础设施建设。

局限性

  • 纳入试验中4项为高偏倚风险。
  • Apgar评分以外的新生儿结局报告不一致。
  • 仅8项试验、1813例妊娠,样本量有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Remote and home-based fetal heart rate monitoring may improve access, convenience, and continuity of care, but whether it provides perinatal safety and obstetric outcomes comparable to conventional in-person monitoring remains uncertain. OBJECTIVE: To evaluate whether remote fetal heart rate monitoring is associated with neonatal and obstetric outcomes comparable to conventional in-person fetal heart rate monitoring in randomized controlled trials. STUDY DESIGN: MEDLINE, Embase, and the Cochrane Central Register of Controlled Trials (CENTRAL) were searched from database inception through November 25, 2025. Reference lists of relevant reviews and included studies were screened for additional eligible trials. Randomized controlled trials enrolling pregnant individuals undergoing antenatal surveillance or intrapartum monitoring were eligible if they compared remote or home-based fetal heart rate monitoring with conventional in-person monitoring and reported obstetric or perinatal outcomes. RESULTS: Eight randomized controlled trials enrolling 1,813 pregnancies were included. One trial was judged at low risk of bias, 3 had some concerns, and 4 were judged at high risk. Six trials (n=1,648) reported 5-minute Apgar scores <7; the pooled risk ratio was 1.01 (95% CI, 0.73-1.39; I²=0%; τ²=0.00), representing moderate-certainty evidence. Cesarean delivery was reported by all 8 trials (n=1,813); the pooled risk ratio was 1.09 (95% CI, 0.94-1.26; I²=0%), also representing moderate-certainty evidence. Prespecified subgroup analyses showed no evidence that effects differed by monitoring timing (antepartum vs intrapartum; Qb=1.26, P=.26) or publication era (≥2015 vs <2015; Qb=1.52, P=.22). CONCLUSIONS: In randomized evidence, remote and home-based fetal heart rate monitoring was not associated with differences in 5-minute Apgar scores <7 or cesarean delivery compared with conventional in-person monitoring. Findings were consistent across monitoring settings and technology eras, although several trials had high risk of bias and neonatal outcomes beyond Apgar score were inconsistently reported. Adoption should therefore consider not only short-term perinatal safety but also access, patient satisfaction, hospital utilization, clinician workload, data reliability, cost, and infrastructure for timely clinical response. El resumen está disponible en Español al final del artículo.

来源:Am J Obstet Gynecol MFM,查看原文。版权归原作者所有。

引用

  1. Erden M, Kalafat E, Jones I, et al. Remote and home-based fetal heart rate monitoring for fetal surveillance compared with conventional in-person monitoring: a systematic review and meta-analysis of randomized controlled trials. Am J Obstet Gynecol MFM. 2026. PMID: 42486230. doi:10.1016/j.ajogmf.2026.102072

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。